Replies to post #90808 on $heff's $tation of $tocks & $olid DD

[gambler2075]

$SPHS Price target currently 4$.
Thanks for posting that prior Leerink review from March... IMO, that was pretty much during the midst of the negativity... P3 results were still 6+ months away at that time.

Now, the P3 trial has finished (according to the interim results PR from Dec 2015) and we are just awaiting the final results/data analysis.

http://investor.sophiris.com/releasedetail.cfm?ReleaseID=887602

"...after the last patient completes the study, which is anticipated to be in September 2015"

Anyway, the most recent price target I have seen is 4$, which was reiterated yesterday.

http://www.investornewswire.com/analyst-views/ratings-and-sentiment-update-on-sophiris-bio-inc-nasdaqsphs/46889/

g